Severity
Moderate
ModerateActive
CPSC recall · Reported April 30, 2026
Bayer Recalls 6 mL Size Afrin Original Nasal Spray Bottles Due to Risk of Serious Injury or Illness from Child Poisoning; Violates Mandatory Standard for Child-Resistant Packaging
The 6 mL nasal sprays contain an imidazoline, which must be in child-resistant packaging or meet the labeling requirements for non-complying packaging, as required by the Poison P…
Compiled from official public sources by the editorial team.
Verify with CPSC →
Bayer HealthCare LLC, of Whippany, New Jersey recalled This recall involves unexpired Travel Size Afrin® Original Nasal Spray 6 mL bottles, with… - a moderate-severity action.
Bayer Recalls 6 mL Size Afrin Original Nasal Spray Bottles Due to Risk of Serious Injury … was recalled by Bayer HealthCare LLC, of Whippany, New Jersey in April 30, 2026. Reason: The 6 mL nasal sprays contain an imidazoline, which must be in child-resistant packaging or meet the labeling…. Remedy: Consumers should immediately secure the recalled bottles out of sight and reach of childr…. Verify recall #26455 with the CPSC before acting.
The recall
Bayer HealthCare LLC, of Whippany, New Jersey issued this moderate-severity CPSC recall-The 6 mL nasal sprays contain an imidazoline, which must be in child-resistant packaging or meet the labeling….
- Moderate
- severity level
- April 30, 2026
- reported
Sourced from official CPSC enforcement records. Verify recall #26455 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.
Recall Insight
This CPSC action (record #26455) was formally reported on April 30, 2026. It is classified under Moderate severity, with a current status of Active. Bayer HealthCare LLC, of Whippany, New Jersey is listed as the recalling firm. Federal records list the affected scope as About 786,100.
The documented reason for this recall is: The 6 mL nasal sprays contain an imidazoline, which must be in child-resistant packaging or meet the labeling requirements for non-complying packaging, as required by the Poison Prevention Packaging Act. The 6 mL nasal … Distribution information was not included in the agency filing, so consumers should assume broad potential exposure until the firm publishes point-of-sale details. The remedy documented by the agency is: Consumers should immediately secure the recalled bottles out of sight and reach of children and go to the webform posted on www.livewell.bayer.com/afrin-original-spray-recall to begin a request for a… - consumers holding this product should act on that instruction rather than relying on general guidance.
Within the same product category the archive holds 6 closely related recalls, 6 from CPSC - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.
Children & Baby Products recalls over time
Where this recall sits in its category - 3,731 children & baby products recalls on record
Of 101,704 recalls in the database, 24,878 are high severity, 72,426 moderate, and 4,400 low. This recall is classified moderate severity.
Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.
Affected scope
About 786,100
Related Recalls
6
6 from same agency
Product description
This recall involves unexpired Travel Size Afrin® Original Nasal Spray 6 mL bottles, with Lot numbers 230361, 240822, 241198, 250066, 250152, 250646, and 250831. These travel size bottles have "Afrin® Original Nasal Spray" and "1/5 FL OZ (6 mL)" printed on a label located on the front of the bottle. It is a six-digit number, followed by the expiration date in following format: "YYYYMMM". No other sizes of Afrin are included in this recall.
Reason for recall
The 6 mL nasal sprays contain an imidazoline, which must be in child-resistant packaging or meet the labeling requirements for non-complying packaging, as required by the Poison Prevention Packaging Act. The 6 mL nasal spray's packaging is not child-resistant nor bears the required labeling statement, posing a risk of serious injury or illness from poisoning, if the contents are swallowed by young children.
Remedy, what to do
Consumers should immediately secure the recalled bottles out of sight and reach of children and go to the webform posted on www.livewell.bayer.com/afrin-original-spray-recall to begin a request for a refund. Consumers will be asked to take and submit a photo of the product before disposing of it in order to receive a refund.
Recall Profile
| Attribute | Value |
|---|---|
| Agency | U.S. Consumer Product Safety Commission |
| Severity class | Moderate |
| Status | Active |
| Recall number | 26455 |
| Date reported | April 30, 2026 |
| Date initiated | April 30, 2026 |
| Recalling firm | Bayer HealthCare LLC, of Whippany, New Jersey |
| Affected scope | About 786,100 |
| Distribution | Not disclosed |
| Official source | CPSC notice → |
Profile values are sourced directly from the official CPSC enforcement record. Source: U.S. Consumer Product Safety Commission.
What to do with this recall
Consumers should immediately secure the recalled bottles out of sight and reach of children and go to the webform posted on www.l…
- Check the recall number (26455) and product description against the item you own. Search the archive
- Confirm the current status and remedy on the official CPSC notice before acting. CPSC notice
- Follow the documented remedy (refund, replacement, repair, or disposal) rather than general advice. What to do next
This page summarizes the official CPSC record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.
Frequently Asked Questions
What product was recalled? ▼
This recall involves unexpired Travel Size Afrin® Original Nasal Spray 6 mL bottles, with Lot numbers 230361, 240822, 241198, 250066, 250152, 250646, and 250831. These travel size bottles have "Afrin® Original Nasal Spray" and "1/5 FL OZ (6 mL)" printed on a label located on the front of the bottle. It is a six-digit number, followed by the expiration date in following format: "YYYYMMM". No other sizes of Afrin are included in this recall.. Recalled by Bayer HealthCare LLC, of Whippany, New Jersey. Units affected: About 786,100.
Why was this product recalled? ▼
The 6 mL nasal sprays contain an imidazoline, which must be in child-resistant packaging or meet the labeling requirements for non-complying packaging, as required by the Poison Prevention Packaging Act. The 6 mL nasal spray's packaging is not child-resistant nor bears the required labeling statement, posing a risk of serious injury or illness from poisoning, if the contents are swallowed by young children.
What should consumers do? ▼
Consumers should immediately secure the recalled bottles out of sight and reach of children and go to the webform posted on www.livewell.bayer.com/afrin-original-spray-recall to begin a request for a refund. Consumers will be asked to take and submit a photo of the product before disposing of it in order to receive a refund.
Which agency issued this recall? ▼
This recall was issued by the CPSC on April 30, 2026. Severity: Moderate. Recall number: 26455.
How do I check if my product is affected by a recall? ▼
Check the product description and recall number (26455) against your product. Visit the official CPSC website for the most current information. You can also use our Recall Checker tool to search by product name or brand.
How do I report an injury from a recalled product? ▼
Report injuries to the issuing agency: CPSC at SaferProducts.gov, NHTSA at nhtsa.gov/report-a-safety-problem, or FDA via MedWatch. Document the product (photos, model/serial numbers, purchase receipts) and seek medical attention. Injury reports help agencies track hazard patterns and may strengthen enforcement actions.
Nearby Recalls in This Category
Other recalls in the same product category, useful for spotting patterns across the same defect class or manufacturer.
CPSC Moderate
AMASKY Nursing Pillows Recalled Due to Risk of Serious Injury or Death from Suffocation; Violate Mandatory Standards fo…
Xishentang Dongguan Trading Co, Ltd., dba Pretty-Life, of China · 2026-07-02
CPSC Moderate
Diamond Wipes International Recalls CVS Health Medicated Hemorrhoidal Wipes Due to Risk of Serious Injury or Death from…
Diamond Wipes International, Inc. of Chino, California · 2026-07-02
CPSC Moderate
Junpower CR2032 Lithium Coin Batteries Recalled Due to Risk of Serious Injury or Death from Battery Ingestion Hazard; V…
· 2026-07-02
CPSC Moderate
Target Recalls Gigglescape™ Under the Sea Popping Toy Due to Choking Hazard
· 2026-07-02
CPSC Moderate
Vevor Recalls Baby Loungers Due to Risk of Serious Injury or Death from Entrapment and Fall Hazards; Violate Mandatory …
Sanven Technology Ltd., dba Vevor, of Rancho Cucamonga, California · 2026-07-02
Compare this recall with AMASKY Nursing Pillows Recalled Due to Risk of Serious Inju… →
Every figure on PlainRecalls is rendered directly from official FDA, CPSC and NHTSA recall records, no number is typed in by an editor. This recall: CPSC, reported April 30, 2026. Severity classes follow each agency's own taxonomy (FDA Class I/II/III; CPSC and NHTSA by hazard type), and related-recall context is computed across the full archive. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of July 2026.